Publication | Closed Access

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

Percutaneous Coronary InterventionCardiovascular DiseaseComplete RevascularisationCulprit LesionSurgeryAcute Myocardial InfarctionMultivessel DiseaseMedicineCardiologyCoronary Artery DiseaseRadiologyMyocardial Infarction